Sirolimus Monotherapy for Thrombocytopenia in Primary Antiphospholipid Syndrome: A Pilot Study From a Tertiary Referral Center

BACKGROUND: Thrombocytopenia (TP) is considered as a warning sign of high-risk antiphospholipid syndrome (APS) and sometimes a paradoxical sign of anti-thrombosis treatment. Currently, there is an extreme paucity of effective and safe drugs for long-term management of TP in primary APS patients; the...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Wenhui, Ji, Lanlan, Zhang, Zhuoli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989728/
https://www.ncbi.nlm.nih.gov/pubmed/35401500
http://dx.doi.org/10.3389/fimmu.2022.857424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989728/
https://www.ncbi.nlm.nih.gov/pubmed/35401500
http://dx.doi.org/10.3389/fimmu.2022.857424

Ejemplares similares